Dr. Olivia Todd is Director of Clinical Studies and Academic Collaborations at Sorridi Therapeutics, where she helps turn gut–brain science into meaningful research. With a PhD in Microbiology and training in fungal-bacterial interactions, her background spans basic science, clinical study design, and cross-disciplinary collaboration. At Sorridi, she leads research programs exploring how dietary fibers and microbiome modulation influence inflammation and neurological health, particularly in Parkinson’s disease. Known for her ability to connect data, people, and ideas, Dr. Todd works closely with clinicians, researchers, and industry partners to advance fiber-based interventions and communicate complex microbiome science in clear, human terms.